Plasminogen activator system in oral squamous cell carcinoma

British Journal of Oral and Maxillofacial Surgery

Volumn 45, Issue 8, 2007, Pages 623-627

  Baker, E A ^a   Leaper, D J ^a   Hayter, J P ^b   Dickenson, A J ^c  

^a UNIVERSITY HOSPITAL OF NORTH TEES   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

^c DERBYSHIRE ROYAL INFIRMARY   (United Kingdom)

Author keywords

Metastasis; Oral squamous cell carcinoma; Plasminogen activators

Indexed keywords

PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; UROKINASE RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; METASTASIS; MOUTH CARCINOMA; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TISSUE LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; ENZYME PRECURSORS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PLASMINOGEN ACTIVATORS; PLASMINOGEN INACTIVATORS; RECEPTORS, CELL SURFACE; TISSUE PLASMINOGEN ACTIVATOR; TUMOR MARKERS, BIOLOGICAL; URINARY PLASMINOGEN ACTIVATOR;

EID: 35848940540     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjoms.2007.04.021     Document Type: Article

References (24)

1. Ellis V., Scully M., and Kakkar V.V. Plasminogen activation initiated by single chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J Biol Chem 264 (1989) 2185-2188
2. Syrovets T., and Simmet T. Novel aspects and new roles for the serine protease plasmin. Cell Mol Life Sci 61 (2004) 873-885
3. Kluft C., Dooijewaard G., and Emeis J.J. Role of the contact system in fibrinolysis. Semin Thromb Hemost 13 (1987) 50-68
4. Dano K., Andreasen P.A., Grondahl-Hansen J., Kristensen P., Nielsen L.S., and Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44 (1985) 139-266
5. Gandolfo G.M., Conti L., and Vercillo M. Fibrinolysis components as prognostic markers in breast cancer and colorectal carcinoma. Anticancer Res 16 (1996) 2155-2159
6. Duffy M.J. The urokinase plasminogen activator system: role in malignancy. Curr Pharm Des 10 (2004) 39-49
7. Bouchet C., Spyratos F., Martin P.M., Hacene K., Gentile A., and Oglobine J. Prognostic value of urokinase type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas. Br J Cancer 69 (1994) 398-405
8. Baker E.A., Bergin F.G., and Leaper D.J. Plasminogen activator system, vascular endothelial growth factor and colorectal cancer progression. Mol Pathol 53 (2000) 307-312
9. Stephens R.W., Nielsen H.J., christensen I.J., et al. Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J Natl Cancer Inst 91 (1999) 869-874
10. Curino A., Patel V., Nielsen B.S., et al. Detection of plasminogen activators in oral cancer by laser capture microdissection combined with zymography. Oral Oncol 40 (2004) 1026-1032
11. Ljungner H., Bjorlin G., and Astedt B. Immunological identification of plasminogen activators in normal and malignant tissues in oral cavity in man. Int J Oral Surg 13 (1984) 334-338
12. Barlow Y., and Southam J.C. Plasminogen activators in normal and malignant oral epithelium in vivo and in vitro. Arch Oral Biol 37 (1992) 749-756
13. Hundsdorfer B., Zeilhofer H.F., Bock K.P., et al. Tumour associated urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in normal and neoplastic tissues of patients with squamous cell cancer of the oral cavity-clinical relevance and prognostic value. J Craniomaxillofac Surg 33 (2005) 191-196
14. Hundsdorfer B., Zeilhofer H.F., Bock K.P., Dettmar P., Schmitt M., and Horch H.H. Prognostische Bedeutung des Plasminogenaktivators vom Urokinasetyp (uPA) und des Plasminogenaktivator-Inhibitors (PAI-1) beim primär resezierten Plattenepithelkarzinom der Mundhöhle (The prognostic importance of urokinase type plasminogen activator (uPA) and plasminogen activator inhibitors (PAI-1) in the primary resection of oral squamous cell carcinoma.). Mund Kiefer Gesichtschir 8 (2004) 173-179
15. Hundsdorfer B., Zeilhofer H.F., Bock K.P., Dettmar P., Schmitt M., and Horch H.H. Vergleich des Plasminogenaktivators vom Urokinasetyp (uPA) und des Plasminogenaktivator-Inhibitors (PAI-1) mit klinischen Parametern beim resezierten Plattenepithelkarzinom der Mundhöhle (Comparison of urokinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in primary resection of oral squamous cell carcinoma.). Mund Kiefer Gesichtschir 8 (2004) 180-190 abstract only
16. Liang X., Mao Z., and He Y. The expression of urokinase -type plasminogen activator in oral squamous cell carcinoma. Hua Xi Kou Qiang Yi Xue Za Zhi 21 (2003) 147-149 abstract only
17. Tsai M.H., Chen W.C., Chen H.Y., and Tsai F.J. Urokinase Gene 3′-UTR T/C polymorphism is associated with oral cancer. J Clin Lab Anal 18 (2004) 276-279
18. Pasini F.S., Brentani M.M., Kowalski L.P., and Federico M.H.H. Transforming growth factor β1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous cell carcinoma and normal adjacent mucosa. Head Neck 23 (2001) 725-732
19. Strojan P., Budihna M., Smid L., Vrhovec I., and Skrk J. Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients. Eur J Cancer 34 (1998) 1193-1197
20. Clayman G., Wang S.W., Nicolson G.L., et al. Regulation of urokinase-type plasminogen activator expression in squamous-cell carcinoma of the oral cavity. In J Cancer 54 (1993) 73-80
21. Petruzzelli G.J., Snyderman C.H., and Johnson J.T. In vitro urokinase plasminogen activator levels and total plasminogen activator activity in squamous cell carcinomas of the head and neck. Arch Otolaryngol Head Neck Surg 120 (1994) 989-992
22. Nozaki S., Endo Y., Kawashiri S., et al. Immunohistochemical localization of urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis. Oral Oncol 34 (1998) 58-62
23. Itaya T., Suzuki K., Takagi I., Motai H., and Baba S. Relationship between head and neck squamous cell carcinomas and fibrinolytic factors. Acta Otolaryngol (Suppl.) 525 (1996) 113-119
24. Ohnishi S.T., and Barr J.K. A simplified method of quantitating proteins using the biuret and phenol reagents. Anal Biochem 86 (1978) 193-200